Search Results

Endovascular Treatments for Critical Limb Ischemia

The past, present, and future of treating this disease.

By Jeffrey H. Freihage, MD, and Robert S. Dieter, MD, RVT

High-Risk Pulmonary Embolism in Pregnancy: What Every Interventionalist Should Know

An overview of diagnosis, management, and the role of advanced therapies for high- and intermediate-high–risk pulmonary embolism.

By Vivian Bishay, MD

Lung Ablation

Panelists: Kamran Ahrar, MD, MBA; Sharjeel H. Sabir, MD; Alda L. Tam, MD; Robert Suh, MD; Peter J. Littrup, MD; and Damian E. Dupuy, MD, FACR

Cataract Development in Vascular Intervention

An analysis of risk and the appropriate preventive measures.

By Kevin Seals, MD; Harry Trieu, BS; Stephen Kee, MD; and Edward Wolfgang Lee, MD, PhD

Inferior Vena Cava Filters

Today's clot filtration technologies offer a variety of options.

By ANNE C. ROBERTS, MD

Yttrium-90 Radioembolization

Recent advances in hepatic embolotherapy.

By David M. Liu, MD, FRCP(C); David N. Cade, MD; Jesse Knight, MD; Rodney Raabe, MD; Stephen Kee, MD; Andrew Kennedy, MD, FACRO; and Riad Salem, MD, FSIR, MBA

Y-90 Radioembolization for Colorectal Liver Metastases

Intra-arterial treatment options based on current data.

By Siobhan Flanagan, MD; Donna D'Souza, MD; and Jafar Golzarian, MD

Technical Dos and Don'ts of Radiation Segmentectomy and Same-Day Y-90 Treatment

Contemporary radioembolization techniques and the approaches to avoid.

By Ahmed Gabr, MD; Robert J. Lewandowski, MD, FSIR; Riad Salem, MD; and Ahsun Riaz, MD

Hepatoma: Image-Guided Treatment Options in 2016

An overview of the interventional oncologist's arsenal.

By Jeffrey R. Ramkaransingh, MD, and Matthew S. Johnson, MD, FSIR

Successful Endovenous Ablation

Is it the technology or the technique?

By Steve Elias, MD, with Jose I. Almeida, MD; Peter Gloviczki, MD; Nick Morrison, MD; and Julianne Stoughton, MD

Competing Responsibly: A Venous Industry Roundtable

Representatives from industry provide their perspectives on training, ensuring ethical use of venous products, and industry's role in value-based care and collaborating with societies to establish best practices.

Moderator: Steve Elias, MD, FACS, FACPh
Panel: David Goodman, Eric Heil, and Sandra Lesenfants

An Interview with Zvonimir Krajcer, MD

A leading interventional cardiologist discusses percutaneous AAA repair, the role of creativity in intervention, and features of the C3 Conference.

By Zvonimir Krajcer, MD

Collaborating to Treat Venous Thromboembolism

Involving the emergency department in interventional management of VTE.

By Charles V. Pollack Jr, MA, MD, FACEP, FAAEM, FAHA

Roundtable Discussion: COVID-19 and Lower Extremity Revascularization

How the onset of COVID-19 has affected patient selection, resources, staffing, and safety.

With Sharif Ellozy, MD; Katherine Gallagher, MD; William A. Gray, MD; Lorenzo Patrone, MD; Sreekumar Madassery, MD; Zola N’Dandu, MD, FSCAI; and Richard F. Neville, MD, FACS, DFSVS, RCPSG (Hon)

Perspectives: PEVAR in Practice

Peter R. Nelson, MD, MS, FACS, and Benjamin W. Starnes, MD, FACS, share their insights on the learning curve, benefits, and considerations involved in choosing a percutaneous approach to EVAR.

By Peter R. Nelson, MD, MS, FACS, and Benjamin W. Starnes, MD, FACS